On the other hand, the Observing Fibrosis, Macular Atrophy and Subretinal Highly Reflective Material, Before and After Intervention with anti-VEGF Treatment (FASBAT) study compared the increase of macular atrophy prevalence before and after initiation of anti-VEGF therapy and reported that early diagnosis of nAMD does not influence the prevalence of macular atrophy [43]. Here, VEGFA is linked to fibrosis.